日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SARS-CoV-2 specific adaptations in N protein inhibit NF-κB activation and alter pathogenesis.

SARS-CoV-2 特异性 N 蛋白适应性改变抑制 NF-κB 激活并改变发病机制

Guo Xiao, Yang Shimin, Cai Zeng, Zhu Shunhua, Wang Hongyun, Liu Qianyun, Zhang Zhen, Feng Jiangpeng, Chen Xianying, Li Yingjian, Deng Jikai, Liu Jiejie, Li Jiali, Tan Xue, Fu Zhiying, Xu Ke, Zhou Li, Chen Yu

Real-Time, Risk-Based Clinical Trial Quality Management in China: Development of a Digital Monitoring Platform

中国实时、基于风险的临床试验质量管理:数字化监查平台的开发

Jiang, Min; Zhao, Shuhua; Mei, Yun; Fu, Zhiying; Yuan, Yannan; Ai, Jie; Sheng, Yuan; Gong, Ying; Chen, Jingjing

Data Flow Construction and Quality Evaluation of Electronic Source Data in Clinical Trials: Pilot Study Based on Hospital Electronic Medical Records in China

临床试验中电子源数据的数据流构建与质量评价:基于中国医院电子病历的试点研究

Yuan, Yannan; Mei, Yun; Zhao, Shuhua; Dai, Shenglong; Liu, Xiaohong; Sun, Xiaojing; Fu, Zhiying; Zhou, Liheng; Ai, Jie; Ma, Liheng; Jiang, Min

Human adenoviruses: A suspect behind the outbreak of acute hepatitis in children amid the COVID-19 pandemic

人类腺病毒:新冠肺炎疫情期间儿童急性肝炎爆发的嫌疑病毒之一

Wang, Hongyun; Yang, Shimin; Liu, Jiejie; Fu, Zhiying; Liu, Yingle; Zhou, Li; Guo, Haitao; Lan, Ke; Chen, Yu

Safety and efficacy of bevacizumab combined with R-CHOP regimen in seven Chinese patients with untreated diffuse large B-cell lymphoma

贝伐珠单抗联合R-CHOP方案治疗7例未经治疗的中国弥漫性大B细胞淋巴瘤患者的安全性和有效性

Fu, Zhiying; Zhu, Jun; Zheng, Wen; Liu, Weiping; Ying, Zhitao; Xie, Yan; Wang, Xiaopei; Lin, Ningjing; Tu, Meifeng; Ping, Lingyan; Deng, Lijuan; Zhang, Chen; Ding, Ning; Song, Yuqin

Single nucleotide polymorphisms of CD20 gene and their relationship with clinical efficacy of R-CHOP in patients with diffuse large B cell lymphoma.

CD20 基因的单核苷酸多态性及其与 R-CHOP 治疗弥漫性大 B 细胞淋巴瘤患者的临床疗效的关系

Ding Huirong, Jin Xuan, Ding Ning, Fu Zhiying, Song Yuqin, Zhu Jun

Homozygous A polymorphism of the complement C1qA276 correlates with prolonged overall survival in patients with diffuse large B cell lymphoma treated with R-CHOP

补体C1qA276的纯合A多态性与接受R-CHOP方案治疗的弥漫性大B细胞淋巴瘤患者的总生存期延长相关。

Jin, Xuan; Ding, Huirong; Ding, Ning; Fu, Zhiying; Song, Yuqin; Zhu, Jun